WALTHAM, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming 2008 UBS Global Healthcare Services Conference being held February 11 through 13, 2008 at the Grand Hotel Hyatt in New York City. Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend. Their presentation is scheduled for Wednesday, February 13, 2008 at 8:30 a.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and the UBS Investment Bank website at http://www.ibb.ubs.com. A replay of the webcast will be available via the links above for approximately one month from the date of the webcast. During their presentation Mr. Zwanziger and Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.
The investor presentation used at the conference will be made available on the Company's website at http://www.invmed.com/presentations.cfm.
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.
|SOURCE Inverness Medical Innovations|
Copyright©2008 PR Newswire.
All rights reserved